Search

everythinglearnresearchcommunity

for

Search:↓

Post-COVID-19 patients often experience musculoskeletal issues, fitness decline, behavioral changes, chest pain, cough, hair loss, and nervous system problems.

Some COVID-19 pneumonia patients in Veracruz, Mexico, had skin issues, with reversible hair loss linked to disease severity.

Canakinumab's effect on COVID-19 outcomes is unclear.

Some drugs may help treat both COVID-19 and radiation injury.

Different types of hair loss are linked to COVID-19, with some types possibly increasing risk of getting the virus, while others may be triggered or worsened by the virus.

MAIT cells may help fight COVID-19 but also contribute to severe inflammation.

Some COVID-19 pneumonia patients in Veracruz, Mexico had rare skin issues like temporary hair loss linked to disease severity.

Certain skin rashes can indicate COVID-19 severity, with chilblains-like rashes linked to milder cases and livedoid patterns to more severe cases.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Testosterone's effects on COVID-19 are unclear and need more research.

Long-term effects of COVID-19 can vary over time and are more likely in certain age and gender groups, while race, income, and education levels have little to no impact. Ongoing medical care is needed due to potential complications.

Herpes zoster can occur with COVID-19 even in healthy individuals.

The Pfizer COVID-19 vaccine may rarely trigger nail psoriasis.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.

The research found that COVID-19 survivors experienced long-term effects like anemia and hypertension, with age and gender being important factors, but race, income, and education had little to no impact.

During the COVID-19 lockdown, there were fewer cases of mild skin issues and more cases of stress-related skin conditions.

Hydroxychloroquine and chloroquine are not recommended for COVID-19 treatment due to insufficient evidence and safety concerns.

A certain genetic variant in the androgen receptor may predict the severity of COVID-19 in men.

Fungal infections are common in severe COVID-19 cases but their impact on disease severity is unclear.

The letter suggests testosterone replacement therapy might worsen COVID-19 outcomes.

People with blood group O may have a higher risk of developing post-COVID-19 syndrome.

Anti-androgen therapy might help protect against COVID-19 infection and reduce death risk.

Nailfold dermoscopy is a simple, cheap way to check blood vessel changes in COVID-19 patients.

Insulin resistance linked to obesity may increase COVID-19 severity.

Higher oxidative stress markers are linked to hair loss in post-COVID-19 patients.

Collider bias can distort our understanding of COVID-19 risk and severity.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Grey hair and baldness may be linked to COVID-19 severity, but more analysis is needed; post-infectious hair loss is related to the severity of the disease and usually recovers within 3-6 months.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.